A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers
Clinical trial NCT02166398 · COMPLETED
Trial details
- NCT number
- NCT02166398
- Sponsor
- Korea United Pharm. Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-10-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.